More News

05 Jun 2020 UCB acquires Engage Therapeutics: Staccato® Alprazolam - A potential solution for acute on-demand seizure management for people living with epilepsy
04 Jun 2020 Targovax Enters Collaboration With Leidos to add Checkpoint Inhibitor Functionality to ONCOS Viruses
04 Jun 2020 Ferring and Igenomix Collaborate to Advance Care in Reproductive Medicine and Maternal Health Ferring and Igenomix Collaborate to Advance Care in Reproductive Medicine and Maternal Health
04 Jun 2020 AstraZeneca to discover and develop novel therapies targeting RNA-modifying proteins in oncology collaboration with Accent Therapeutics
03 Jun 2020 Novellus Executes Exclusive Worldwide License Agreement with Plexxikon for PLX8394, Plexxikon’s Next-Generation, Clinical Stage BRAF Inhibitor
03 Jun 2020 Aduro Biotech and Chinook Therapeutics Announce Definitive Merger Agreement
01 Jun 2020 Regeneron and Intellia Therapeutics Expand Collaboration to Develop CRISPR/Cas9-Based Treatments
01 Jun 2020 AbbVie and Jacobio Announce Strategic Collaboration to Advance SHP2 Inhibitors
28 May 2020 EdiGene and Immunochina Announce Research and Development Collaboration to Develop Allogeneic CAR-T Therapy for Cancer
28 May 2020 Sensei Biotherapeutics Completes Acquisition of Alvaxa Biosciences, a Camelid Antibody Therapeutics Company
27 May 2020 Gilead Sciences and Arcus Biosciences Establish 10-year Partnership to Co-develop and Co-commercialize Next-generation Cancer Immunotherapies
27 May 2020 Repare Therapeutics Announces Multi-Target Discovery Collaboration with Bristol Myers Squibb
26 May 2020 Tetra Therapeutics Enters Into Definitive Merger Agreement To Be Acquired by Shionogi
26 May 2020 Merck to Acquire Themis
26 May 2020 Merck and Ridgeback Bio Collaborate to Advance Development of Novel Antiviral Candidate, EIDD-2801
25 May 2020 Tavotek Announces a Research Agreement with Genmab for the Development of Bispecific Antibodies using Genmab's DuoBody® Platform against a Pair of Disease Relevant Targets
23 May 2020 AbCellera Announces Multi-Year Antibody Discovery Collaboration with Lilly
20 May 2020 Atea Pharmaceuticals Announces IND Clearance of AT-527 for COVID-19 and $215 Million Financing
19 May 2020 Vividion Therapeutics Announces Drug Discovery Collaboration with Roche Focused on Novel E3 Ligases
18 May 2020 OSE Immunotherapeutics Presents CLEC-1, Novel Myeloid Immune Checkpoint Target for Cancer Immunotherapy
16 May 2020 LegoChem Biosciences and Iksuda Enter Licensing Agreement for Antibody Drug Conjugate Program
14 May 2020 Recursion Enters Into Global Licensing Agreement with Takeda to Develop TAK-733 in Hereditary Cancer Syndrome
14 May 2020 Skyhawk Therapeutics Announces Expansion of its Collaboration Agreement with Merck to Discover and Develop Novel Small Molecules that Modulate RNA...
13 May 2020 Boehringer Ingelheim Collaborates with CDR-Life to Develop Antibody Fragment-based Therapeutics for Geographic Atrophy, a Leading Cause of Blindness Worldwide
12 May 2020 Neurocrine Biosciences exercises option to license Idorsia's novel treatment for rare pediatric epilepsy

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up